SAB Biotherapeutics, Inc.
NASDAQ:SABSBiotechnology
Healthcare
$2.91 -0.53%
-$0.02 today
- Market cap
- $262.16M
- Beta
- 0.53
- P/E (TTM)
- 3.0
- EPS (TTM)
- -$0.16
52W Low $1.85High $5.15
Volume 1.75M
Average 0.76M
Price history
SAB Biotherapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-23.42%
Period high
$4.59
Period low
$2.49
Latest
$2.91
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 5, 2026 | Nov 5, 2026 | |
| 25-NSE | Oct 22, 2026 | Oct 22, 2026 | |
| 8-K | Oct 13, 2026 | Oct 13, 2026 | |
| 4 | Sep 18, 2026 | Sep 18, 2026 | |
| 424B3 | Aug 21, 2026 | Aug 21, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G | Aug 12, 2026 | Aug 12, 2026 | |
| SC 13D/A | Aug 10, 2026 | Aug 10, 2026 | |
| 10-Q | Aug 6, 2026 | Aug 6, 2026 | |
| 8-K | Jul 7, 2026 | Jul 7, 2026 |
Competitors
Who does SAB Biotherapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about SABS's filings, answered from its disclosures.
What is the latest SABS filing?
The latest filing shown is 10-Q dated Nov 5, 2026.
How many recent filings does SABS have?
Intrinsic Alpha currently shows 20 recent filings for SABS.
Continue the stock analysis
Jump to another research area for this company.